Evidence map›Paper›PMID 35479482›Full record

ArticleRSC advances2021

Promising antimicrobial and antibiofilm activities of reduced graphene oxide-metal oxide (RGO-NiO, RGO-AgO, and RGO-ZnO) nanocomposites.

Sherif Elbasuney, Gharieb S El-Sayyad, Hesham Tantawy, Amr H Hashem

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. RETRACTED: Mycosynthesis of Hematite (α-FeBioengineering (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Sherif ElbasuneyHead of Nanotechnology Research Center, Military Technical College (MTC) Egyptian Armed Forces, Kobry Elkobbah Cairo 262-111 Egypt.
Gharieb S El-SayyadChemical Engineering Department, Military Technical College (MTC) Egyptian Armed Forces, Kobry Elkobbah Cairo 262-111 Egypt.ORCID https://orcid.org/0000-0001-5410-7936
Hesham TantawyChemical Engineering Department, Military Technical College (MTC) Egyptian Armed Forces, Kobry Elkobbah Cairo 262-111 Egypt.
Amr H HashemBotany and Microbiology Department, Faculty of Science, Al-Azhar University Cairo 11884 Egypt amr.hosny86@azhar.edu.eg.ORCID https://orcid.org/0000-0002-0024-3606
Applied Nanotech (United States) · USCairo University · EGEgyptian Atomic Energy Authority · EGMilitary Technical College · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial infections are considered one of the most dangerous infections in humans due to their resistance to most antimicrobial agents. In this study, nanocomposites based on reduced graphene oxide (RGO) and metal oxides (NiO, AgO, and ZnO) were fabricated. The graphite precursor and RGO were characterized by XRD, Raman spectroscopy, SEM, and HRTEM, while SEM, XRD, and EDX mapping analysis validated the synthesized nanocomposites. In addition, ZOI and MIC were employed to test the antimicrobial potential, while their antibiofilm activity and the effect of UV illumination were also investigated. Finally, reaction mechanism determination was performed using SEM analysis. The results revealed that all the synthesized nanocomposites (RGO-NiO, RGO-AgO, and RGO-ZnO) had outstanding antimicrobial activity against Gram-negative bacteria (

Identifiers

PMID35479482
PMCPMC9037130
OpenAlexW3183143754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.